Deuteria Pharmaceuticals, Inc.
Records under this name other than the patents Deuteria Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.
Back to Deuteria Pharmaceuticals, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,531,685 | Deuterium-enriched oxybutynin Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,735,454 | Deuterium-Enriched Bupropion Formerly held In force · High confidence | In force | High confidence | |
| US 9,925,175 | Deuterium-enriched pioglitazone Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,576,071 | Deuterium-enriched pioglitazone Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,940,143 | Deuterium-enriched pioglitazone Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,524,780 | Deuterium-Enriched Bupropion Formerly held In force · High confidence | In force | High confidence | |
| US 11,918,567 | Deuterium-enriched pioglitazone Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,722,710 | Deuterium-enriched pioglitazone Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,090,585 | 2,6-dioxo-3-deutero-piperdin-3-yl-isoindoline compounds Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,304,435 | Deuterium-enriched donepezil Formerly held Lapsed on the fee record Ended Nov 6, 2024 · USPTO record | Lapsed on the fee record | Ended Nov 6, 2024 | USPTO record |